Insider filing · NBIX
Darin Lippoldt
Chief Legal Officer
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Darin Lippoldt sold $1.8M of Neurocrine Biosciences (NBIX)
Executed Jul 9, disclosed Jul 13, 4 days later.
Value, as filed
$1.8M
10,000 sh × $179.60
Executed
Jul 9
the trade date, as filed
Disclosed
Jul 13
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DLDarin Lippoldt (Chief Legal Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (10,000 sh × $179.60, as filed), executed Jul 9.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Darin Lippoldt in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$1.7M9,800 sh across 2 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $699K
4,376 sh × $159.65
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $255K
2,184 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $108K
911 sh × $118.25
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $191K
1,250 sh × $152.91
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET